AVGN
+++now, the resignation of the CFO+++
Funny, I thought of your hypothesis when I saw that.
+++Bob, are you sure aren’t being a sucker here?+++
Been one before, and I was pretty good at it. At the moment I have minimal $ in AVGN - a placeholder, for the most part - and the assets provide a bottom. If by the end of q1 the neuropathy molecule is still a mystery, I'll probably exit.
Regards,
Bob
Market Data 
Markets 
AI
